Neuca Stock price
Compare with Peer Group
Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Neuca Stock Analysis
Analyst Opinions
8 Analysts have issued a Neuca forecast:
Analyst Opinions
8 Analysts have issued a Neuca forecast:
Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.
| Head office | Poland |
| CEO | Piotr Sucharski |
| Employees | 5,172 |
| Founded | 1990 |
| Website | www.neuca.pl |


